Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
ATOS Atossa Therapeutics Inc
OSMT Osmotica Pharmaceuticals PLC
SAND Sandstorm Gold Ltd
GRVI Grove Inc
STON Stonemor Inc
TK Teekay Corp

Health Care : Biotechnology | Small Cap Value
Company profile

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is developing a pipeline of therapeutic programs to address symptoms associated with schizophrenia and psychosis associated with Alzheimer’s disease (AD), as well as various forms of pain. KarXT is a combination of xanomeline and trospium. KarXT combines xanomeline, a muscarinic agonist, with trospium, a muscarinic antagonist, to stimulate muscarinic receptors in the CNS. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms.

Day's Change
-1.05 (-0.85%)
B/A Size
Day's High
Day's Low

Today's volume of 27,695 shares is on pace to be much lighter than KRTX's 10-day average volume of 191,081 shares.


The naked truth on naked shorting

2:09 pm ET October 6, 2021 (MarketWatch)

Thornton McEnery

"Naked shorting"? "Failures to deliver"?

Even a cursory trip through WallStreetBets and other retail investing social media boards will yield multiple references to phrases like "failures-to-deliver" and "naked shorting" with most of those comments linked to the widely-held theory that short-selling chicanery by hedge funds and other institutional traders is the major reason that stocks like GameStop (GME), AMC Entertainment (AMC) and others remain so volatile.

In fact, many retail traders pointed to shady shorting as a key element in AMC's disappointing start to the week in spite of a monster box office weekend.

But what do these things actually mean and what effect do they really have on the markets, especially meme stocks?

On this week's episode of MemeMarkets, we talk to Dr. Susanne Trimbath, an economist and CEO of STP Advisory Services, to get answers to those questions.

For more episodes of MemeMarkets, click this link to subscribe.

-Thornton McEnery


(END) Dow Jones Newswires

October 06, 2021 14:09 ET (18:09 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.